A framework for falsifiable explanations of machine learning models with an application in computational pathology.

Explainable artificial intelligence Falsifiability Tumor segmentation U-Net

Journal

Medical image analysis
ISSN: 1361-8423
Titre abrégé: Med Image Anal
Pays: Netherlands
ID NLM: 9713490

Informations de publication

Date de publication:
11 2022
Historique:
received: 22 09 2021
revised: 11 08 2022
accepted: 18 08 2022
pubmed: 5 9 2022
medline: 25 10 2022
entrez: 4 9 2022
Statut: ppublish

Résumé

In recent years, deep learning has been the key driver of breakthrough developments in computational pathology and other image based approaches that support medical diagnosis and treatment. The underlying neural networks as inherent black boxes lack transparency and are often accompanied by approaches to explain their output. However, formally defining explainability has been a notorious unsolved riddle. Here, we introduce a hypothesis-based framework for falsifiable explanations of machine learning models. A falsifiable explanation is a hypothesis that connects an intermediate space induced by the model with the sample from which the data originate. We instantiate this framework in a computational pathology setting using hyperspectral infrared microscopy. The intermediate space is an activation map, which is trained with an inductive bias to localize tumor. An explanation is constituted by hypothesizing that activation corresponds to tumor and associated structures, which we validate by histological staining as an independent secondary experiment.

Identifiants

pubmed: 36058053
pii: S1361-8415(22)00228-6
doi: 10.1016/j.media.2022.102594
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102594

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

David Schuhmacher (D)

Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Ruhr-University Bochum, Faculty of Biology and Biotechnology, Bioinformatics Group, 44801 Bochum, Germany. Electronic address: david.schuhmacher@rub.de.

Stephanie Schörner (S)

Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Ruhr-University Bochum, Faculty of Biology and Biotechnology, Department of Biophysics, 44801 Bochum, Germany. Electronic address: stephanie.schoerner@rub.de.

Claus Küpper (C)

Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Ruhr-University Bochum, Faculty of Biology and Biotechnology, Department of Biophysics, 44801 Bochum, Germany. Electronic address: claus.kuepper-2@rub.de.

Frederik Großerueschkamp (F)

Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Ruhr-University Bochum, Faculty of Biology and Biotechnology, Department of Biophysics, 44801 Bochum, Germany. Electronic address: frederik.grosserueschkamp@rub.de.

Carlo Sternemann (C)

Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Institute of Pathology, Ruhr-University Bochum, 44789 Bochum, Germany. Electronic address: carlo.sternemann@pathologie-bochum.de.

Celine Lugnier (C)

Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Department of Hematology, Oncology and Palliative Care, Ruhr-University Bochum, St. Josef-Hospital, 44791 Bochum, Germany. Electronic address: Celine.Lugnier@rub.de.

Anna-Lena Kraeft (AL)

Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Department of Hematology, Oncology and Palliative Care, Ruhr-University Bochum, St. Josef-Hospital, 44791 Bochum, Germany. Electronic address: al.kraeft@gmail.com.

Hendrik Jütte (H)

Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Institute of Pathology, Ruhr-University Bochum, 44789 Bochum, Germany. Electronic address: hendrik.juette@rub.de.

Andrea Tannapfel (A)

Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Institute of Pathology, Ruhr-University Bochum, 44789 Bochum, Germany. Electronic address: andrea.tannapfel@pathologie-bochum.de.

Anke Reinacher-Schick (A)

Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Department of Hematology, Oncology and Palliative Care, Ruhr-University Bochum, St. Josef-Hospital, 44791 Bochum, Germany. Electronic address: anke.reinacher@rub.de.

Klaus Gerwert (K)

Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Ruhr-University Bochum, Faculty of Biology and Biotechnology, Department of Biophysics, 44801 Bochum, Germany. Electronic address: Klaus.Gerwert@ruhr-uni-bochum.de.

Axel Mosig (A)

Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Ruhr-University Bochum, Faculty of Biology and Biotechnology, Bioinformatics Group, 44801 Bochum, Germany. Electronic address: axel.mosig@rub.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH